|
Volumn 4, Issue , 1999, Pages 223-235
|
Aquaretics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MOZAVAPTAN;
VASOPRESSIN ANTAGONIST;
VASOPRESSIN V2 RECEPTOR;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
HYPONATREMIA;
INAPPROPRIATE VASOPRESSIN SECRETION;
LIVER CIRRHOSIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
|
EID: 0032952550
PISSN: 13619195
EISSN: None
Source Type: Journal
DOI: 10.1517/14728214.4.1.223 Document Type: Review |
Times cited : (6)
|
References (46)
|